Allen C - Search Results

1

Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease.

Asuzu DT, Alvarez R, Fletcher PA, Mandal D, Johnson K, Wu W, Elkahloun A, Clavijo P, Allen C, Maric D, Ray-Chaudhury A, Rajan S, Abdullaev Z, Nwokoye D, Aldape K, Nieman LK, Stratakis C, Stojilkovic SS, Chittiboina P. Asuzu DT, et al. Among authors: allen c. Cell Rep. 2022 Aug 23;40(8):111223. doi: 10.1016/j.celrep.2022.111223. Cell Rep. 2022. PMID: 36001971 Free PMC article.

2

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches.

Allen CT, Clavijo PE, Van Waes C, Chen Z. Allen CT, et al. Cancers (Basel). 2015 Dec 9;7(4):2397-414. doi: 10.3390/cancers7040900. Cancers (Basel). 2015. PMID: 26690220 Free PMC article. Review.

3

Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.

Moore E, Clavijo PE, Davis R, Cash H, Van Waes C, Kim Y, Allen C. Moore E, et al. Among authors: allen c. Cancer Immunol Res. 2016 Dec;4(12):1061-1071. doi: 10.1158/2326-6066.CIR-16-0104. Epub 2016 Nov 7. Cancer Immunol Res. 2016. PMID: 27821498 Free PMC article.

4

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

Davis RJ, Moore EC, Clavijo PE, Friedman J, Cash H, Chen Z, Silvin C, Van Waes C, Allen C. Davis RJ, et al. Among authors: allen c. Cancer Res. 2017 May 15;77(10):2607-2619. doi: 10.1158/0008-5472.CAN-16-2534. Epub 2017 Mar 31. Cancer Res. 2017. PMID: 28364000 Free PMC article.

5

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.

Clavijo PE, Moore EC, Chen J, Davis RJ, Friedman J, Kim Y, Van Waes C, Chen Z, Allen CT. Clavijo PE, et al. Among authors: allen ct. Oncotarget. 2017 Jun 11;8(34):55804-55820. doi: 10.18632/oncotarget.18437. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915554 Free PMC article.

6

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.

Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C, Hodge JW, Mitchell JB, Friedman J, Allen CT. Morisada M, et al. Among authors: allen ct. Oncoimmunology. 2017 Nov 27;7(3):e1395996. doi: 10.1080/2162402X.2017.1395996. eCollection 2018. Oncoimmunology. 2017. PMID: 29399393 Free PMC article.

7

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.

Moore EC, Sun L, Clavijo PE, Friedman J, Harford JB, Saleh AD, Van Waes C, Chang EH, Allen CT. Moore EC, et al. Among authors: allen ct. Oncoimmunology. 2018 May 7;7(7):e1404216. doi: 10.1080/2162402X.2017.1404216. eCollection 2018. Oncoimmunology. 2018. PMID: 29900037 Free PMC article.

8

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy.

Sun L, Moore E, Berman R, Clavijo PE, Saleh A, Chen Z, Van Waes C, Davies J, Friedman J, Allen CT. Sun L, et al. Among authors: allen ct. Oncoimmunology. 2018 Jul 23;7(10):e1488359. doi: 10.1080/2162402X.2018.1488359. eCollection 2018. Oncoimmunology. 2018. PMID: 30288354 Free PMC article.

9

Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types.

Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR, Jochems C, Clavijo PE, Allen CT, Hodge JW, Tsang KY, Schlom J, Gameiro SR. Hicks KC, et al. Among authors: allen ct. Oncoimmunology. 2018 Jul 30;7(11):e1466018. doi: 10.1080/2162402X.2018.1466018. eCollection 2018. Oncoimmunology. 2018. PMID: 30377559 Free PMC article.

10

Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.

Clavijo PE, Friedman J, Robbins Y, Moore EC, Smith E, Zauderer M, Evans EE, Allen CT. Clavijo PE, et al. Among authors: allen ct. Cancer Immunol Res. 2019 Feb;7(2):282-291. doi: 10.1158/2326-6066.CIR-18-0156. Epub 2018 Dec 4. Cancer Immunol Res. 2019. PMID: 30514791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,752 results

Search Page